Keloid-derived keratinocytes exhibit an abnormal gene expression profile consistent with a distinct causal role in keloid pathology

Wound Repair and Regeneration

Volumn 21, Issue 4, 2013, Pages 530-544

  Hahn, Jennifer M ^a   Glaser, Kathryn ^a   McFarland, Kevin L ^a   Aronow, Bruce J ^b   Boyce, Steven T ^a,c   Supp, Dorothy M ^a,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; CYCLIN D2; CYTOKERATIN 7; DOCKING PROTEIN; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR RUNX2; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1;

ADOLESCENT; ADULT; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; ESSENTIAL GENE; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HOX GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERMEDIATE FILAMENT; KELOID; KERATINOCYTE; MALE; MICROARRAY ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; WOUND HEALING;

ADOLESCENT; ADULT; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROBLASTS; HUMANS; KELOID; KERATINOCYTES; MALE; TRANSCRIPTOME; UP-REGULATION; YOUNG ADULT;

EID: 84879705152     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12060     Document Type: Article

References (43)

1. Butler PD, Longaker MT, Yang GP,. Current progress in keloid research and treatment. J Am Coll Surg 2008; 206: 731-741.
2. Shih B, Garside E, McGrouther DA, Bayat A,. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen 2010; 18: 139-153.
3. Satish L, Babu M, Tran KT, Hebda PA, Wells A,. Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways. Wound Repair Regen 2004; 12: 183-192.
4. Shih B, Bayat A,. Genetics of keloid scarring. Arch Dermatol Res 2010; 302: 319-339.
5. Xia W, Phan TT, Lim IJ, Longaker MT, Yang GP,. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells. Wound Repair Regen 2004; 12: 546-556.
6. Supp DM, Hahn JM, Glaser K, McFarland KL, Boyce S,. Deep and superficial keloid fibroblasts contribute differentially to tissue phenotype in a novel in vivo model of keloid scar. Plast Reconstr Surg 2012; 129: 1259-1271.
7. Kaimal V, Bardes EE, Tabar SC, Jegga AG, Aronow BJ,. ToppCluster: a multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systems. Nucleic Acids Res 2010; 38: W96-102.
8. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T,. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011; 27: 431-432.
9. Biro T, Toth BI, Hasko G, Paus R, Pacher P,. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci 2009; 30: 411-420.
10. Servettaz A, Kavian N, Nicco C, Deveaux V, Chereau C, Wang A, et al. Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis. Am J Pathol 2010; 177: 187-196.
11. Naitoh M, Kubota H, Ikeda M, Tanaka T, Shirane H, Suzuki S, et al. Gene expression in human keloids is altered from dermal to chondrocytic and osteogenic lineage. Genes Cells 2005; 10: 1081-1091.
12. Smith JC, Boone BE, Opalenik SR, Williams SM, Russell SB,. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 2007; 128: 1298-1310.
13. Wang Z, Kundu RK, Longaker MT, Quertermous T, Yang GP,. The angiogenic factor Del1 prevents apoptosis of endothelial cells through integrin binding. Surgery 2012; 151: 296-305.
14. Delague V, Jacquier A, Hamadouche T, Poitelon Y, Baudot C, Boccaccio I, et al. Mutations in FGD4 encoding the Rho GDP/GTP exchange factor FRABIN cause autosomal recessive Charcot-Marie-Tooth type 4H. Am J Hum Genet 2007; 81: 1-16.
15. Law AY, Wong CK,. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells. Exp Cell Res 2010; 316: 3425-3434.
16. De Petrocellis. L, Orlando P, Moriello AS, Aviello G, Stott C, Izzo AA, Di Marzo V., Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiol (Oxf) 2012; 204: 255-266.
17. Rilla K, Lammi MJ, Sironen R, Torronen K, Luukkonen M, Hascall VC, et al. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes. J Cell Sci 2002; 115: 3633-3643.
18. Meyer LJ, Russell SB, Russell JD, Trupin JS, Egbert BM, Shuster S, et al. Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol 2000; 114: 953-959.
19. Bernert B, Porsch H, Heldin P,. Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1). J Biol Chem 2011; 286: 42349-42359.
20. Smith FJ, Porter RM, Corden LD, Lunny DP, Lane EB, McLean WH,. Cloning of human, murine, and marsupial keratin 7 and a survey of K7 expression in the mouse. Biochem Biophys Res Commun 2002; 297: 818-827.
21. Harbaum L, Pollheimer MJ, Kornprat P, Lindtner RA, Schlemmer A, Rehak P, et al. Keratin 7 expression in colorectal cancer-freak of nature or significant finding? Histopathology 2011; 59: 225-234.
22. Sano M, Aoyagi K, Takahashi H, Kawamura T, Mabuchi T, Igaki H, et al. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis. Int J Oncol 2010; 36: 321-330.
23. Peinado H, Moreno-Bueno G, Hardisson D, Perez-Gomez E, Santos V, Mendiola M, et al. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas. Cancer Res 2008; 68: 4541-4550.
24. Rugg EL, Leigh IM,. The keratins and their disorders. Am J Med Genet C Semin Med Genet 2004; 131C: 4-11.
25. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Muller GA, et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002; 61: 1714-1728.
26. Thiery JP, Acloque H, Huang RY, Nieto MA,. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
27. Sun N, Huiatt TW, Paulin D, Li Z, Robson RM,. Synemin interacts with the LIM domain protein zyxin and is essential for cell adhesion and migration. Exp Cell Res 2010; 316: 491-505.
28. Petrof G, Mellerio JE, McGrath JA,. Desmosomal genodermatoses. Br J Dermatol 2012; 166: 36-45.
29. Russell SB, Russell JD, Trupin KM, Gayden AE, Opalenik SR, Nanney LB, et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 2010; 130: 2486-2496.
30. Sato M,. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Acta Derm Venereol 2006; 86: 300-307.
31. Kikuchi A, Yamamoto H, Sato A, Matsumoto S,. Wnt5a: its signalling, functions and implication in diseases. Acta Physiol (Oxf) 2012; 204: 17-33.
32. King TD, Zhang W, Suto MJ, Li Y,. Frizzled7 as an emerging target for cancer therapy. Cell Signal 2012; 24: 846-851.
33. Gailit J, Pierschbacher M, Clark RA,. Expression of functional alpha 4 beta 1 integrin by human dermal fibroblasts. J Invest Dermatol 1993; 100: 323-328.
34. Ong CT, Khoo YT, Mukhopadhyay A, Masilamani J, Do DV, Lim IJ, et al. Comparative proteomic analysis between normal skin and keloid scar. Br J Dermatol 2010; 162: 1302-1315.
35. Hsieh SH, Ying NW, Wu MH, Chiang WF, Hsu CL, Wong TY, et al. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 2008; 27: 3746-3753.
36. Glinka Y, Stoilova S, Mohammed N, Prud'homme GJ,. Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis 2011; 32: 613-621.
37. Mogili NS, Krishnaswamy VR, Jayaraman M, Rajaram R, Venkatraman A, Korrapati PS,. Altered angiogenic balance in keloids: a key to therapeutic intervention. Transl Res 2012; 159: 182-189.
38. Du P, Ye L, Ruge F, Yang Y, Jiang WG,. Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer. Anticancer Res 2011; 31: 3205-3212.
39. Peterfi Z, Donko A, Orient A, Sum A, Prokai A, Molnar B, et al. Peroxidasin is secreted and incorporated into the extracellular matrix of myofibroblasts and fibrotic kidney. Am J Pathol 2009; 175: 725-735.
40. Qi B, Newcomer RG, Sang QX,. ADAM19/adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseases. Curr Pharm Des 2009; 15: 2336-2348.
41. Rinn JL, Wang JK, Liu H, Montgomery K, van de Rijn. M, Chang HY,. A systems biology approach to anatomic diversity of skin. J Invest Dermatol 2008; 128: 776-782.
42. Park JH, Park J, Choi JK, Lyu J, Bae MG, Lee YG, et al. Identification of DNA methylation changes associated with human gastric cancer. BMC Med Genomics 2011; 4: 82.
43. Durani P, Bayat A,. Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg 2008; 61: 4-17.